ARPA-H Awards $144 Million to Seven Teams Racing to Prove FDA-Approved Drugs Can Extend Human Healthspan
The US government's health research agency has funded the first large-scale clinical trials testing whether rapamycin, semaglutide, and other repurposed drugs can slow biological aging in healthy adults, with results expected within three years.
4 min read3 sources